Lung Cancer Clinical Trial

Implementation of Smoking Cessation Within NCI Community Oncology Research Program (NCORP) Sites

Summary

Evaluate a multi-faceted training program to improve short-term smoking cessation rates (<14 days post-visit) and short (3 months) and sustained abstinence (6 months) among 1,114 enrolled smokers who present for low-dose computed tomography (LDCT) lung cancer screening in 26 community-based practices.

View Full Description

Full Description

We utilize an effectiveness-implementation hybrid design, employing a cluster, randomized control trial of community-based NCORP sites to study the effectiveness of a multi-faceted intervention to improve smoking cessation among lung cancer screening patients, as well as dissemination and implementation (D&I) science to optimize and accelerate translation of findings into clinical practice. We will: (1) Evaluate a multi-faceted training program to improve short-term smoking cessation rates (1-week post-visit) and sustained abstinence (6 months) among 1,114 enrolled smokers (557 in each trial arm) who present for LDCT lung cancer screening in community-based lung cancer screening practices; (2) Characterize the adoption and adaptation of the evidence-based tobacco cessation strategies in 26 community-based LDCT lung cancer screening programs; and (3) Develop and evaluate an implementation toolkit for integrating evidence-based tobacco cessation strategies in community-based LDCT lung cancer screening programs. Qualitative data will be collected from key informants at participating screening programs during and after intervention implementation. Quantitative survey data (baseline, <14 days, 3 months, and 6 months) and saliva specimens (6 months only) will be collected from smoking patients receiving screening within these programs.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Agrees to have NCORP research personnel serve as the study liaison and another person to serve as the cessation program champion.
Agrees to participate in all aspects of the intervention, randomization, and evaluation.
Agrees to participate in a confidential 1-on-1 semi-structured interview with the research team.
Agrees to have the interview taped, transcribed and qualitatively analyzed.
Age ≥18 years
Potential participants will be screened using the following question: "Do you smoke cigarettes every day, some days, or not at all?" (BRFSS). A current smoker is anyone responds "every day" or "some days".

Exclusion Criteria:

Current use (previous 30 days) of a tobacco dependence treatment including bupropion, varenicline, and nicotine replacement
Individuals who use e-cigarettes and who are not smoking cigarettes. Dual users (those who use both e-cigarettes and cigarettes) will still be included in the trial.
The presence of a physical or cognitive impairment that would prevent a person from engaging in survey research (such as blindness, deafness, or dementia).
Individual has already completed the intended LDCT lung cancer screening for this study.
Non-English speaking participants.

Study is for people with:

Lung Cancer

Estimated Enrollment:

1094

Study ID:

NCT03291587

Recruitment Status:

Completed

Sponsor:

Wake Forest University Health Sciences

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 45 Locations for this study

See Locations Near You

Helen F Graham Cancer Center
Newark Delaware, 19713, United States
Augusta University Medical Center
Augusta Georgia, 30912, United States
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
Savannah Georgia, 31405, United States
Tripler Army Medical Center
Honolulu Hawaii, 96859, United States
Good Samaritan Regional Health Center
Mount Vernon Illinois, 62864, United States
Carle Cancer Center
Urbana Illinois, 61801, United States
McFarland Clinic PC - Ames
Ames Iowa, 50010, United States
Mercy Medical Center - Des Moines
Des Moines Iowa, 50314, United States
LSU Health Sciences Center at Shreveport
Shreveport Louisiana, 71103, United States
Saint Joseph Mercy Hospital
Ann Arbor Michigan, 48106, United States
Spectrum Health at Butterworth Campus
Grand Rapids Michigan, 49503, United States
William Beaumont Hospital-Royal Oak
Royal Oak Michigan, 48073, United States
Ridgeview Medical Center
Waconia Minnesota, 55387, United States
Saint Louis Cancer and Breast Institute-Ballwin
Ballwin Missouri, 63011, United States
Central Care Cancer Center - Bolivar
Bolivar Missouri, 65613, United States
Cox Cancer Center Branson
Branson Missouri, 65616, United States
Freeman Health System
Joplin Missouri, 64804, United States
Mercy Hospital Joplin
Joplin Missouri, 64804, United States
Delbert Day Cancer Institute at PCRMC
Rolla Missouri, 65401, United States
Mercy Clinic-Rolla-Cancer and Hematology
Rolla Missouri, 65401, United States
Saint Louis Cancer and Breast Institute-South City
Saint Louis Missouri, 63109, United States
Missouri Baptist Medical Center
Saint Louis Missouri, 63131, United States
Mercy Hospital Saint Louis
Saint Louis Missouri, 63141, United States
Mercy Hospital Springfield
Springfield Missouri, 65804, United States
CoxHealth South Hospital
Springfield Missouri, 65807, United States
Mercy Hospital Washington
Washington Missouri, 63090, United States
University Medical Center of Southern Nevada
Las Vegas Nevada, 89102, United States
Saint Mary's Regional Medical Center
Reno Nevada, 89503, United States
Montefiore Medical Center - Moses Campus
Bronx New York, 10467, United States
Novant Health Forsyth Medical Center
Winston-Salem North Carolina, 27103, United States
Sanford South University Medical Center
Fargo North Dakota, 58103, United States
Sanford Roger Maris Cancer Center
Fargo North Dakota, 58122, United States
Adena Regional Medical Center
Chillicothe Ohio, 45601, United States
Mercy Hospital Oklahoma City
Oklahoma City Oklahoma, 73120, United States
Geisinger Medical Center
Danville Pennsylvania, 17822, United States
Prisma Health Cancer Institute - Spartanburg
Boiling Springs South Carolina, 29316, United States
Prisma Health Cancer Institute - Laurens
Clinton South Carolina, 29325, United States
Prisma Health Cancer Institute - Easley
Easley South Carolina, 29640, United States
Prisma Health Cancer Institute - Butternut
Greenville South Carolina, 29605, United States
Prisma Health Cancer Institute - Faris
Greenville South Carolina, 29605, United States
Prisma Health Greenville Memorial Hospital
Greenville South Carolina, 29605, United States
Prisma Health Cancer Institute - Eastside
Greenville South Carolina, 29615, United States
Prisma Health Cancer Institute - Greer
Greer South Carolina, 29650, United States
Prisma Health Cancer Institute - Seneca
Seneca South Carolina, 29672, United States
Baptist Memorial Hospital and Cancer Center-Memphis
Memphis Tennessee, 38120, United States
VCU Massey Cancer Center at Stony Point
Richmond Virginia, 23235, United States
Virginia Commonwealth University/Massey Cancer Center
Richmond Virginia, 23298, United States
Gundersen Lutheran Medical Center
La Crosse Wisconsin, 54601, United States
Aurora Saint Luke's Medical Center
Milwaukee Wisconsin, 53215, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

1094

Study ID:

NCT03291587

Recruitment Status:

Completed

Sponsor:


Wake Forest University Health Sciences

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.